Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity

被引:127
|
作者
Kaplan, Anat Levit [1 ]
Confair, Danielle N. [2 ]
Kim, Kuglae [3 ,4 ]
Barros-Alvarez, Ximena [5 ]
Rodriguiz, Ramona M. [6 ,7 ]
Yang, Ying [1 ]
Kweon, Oh Sang [2 ]
Che, Tao [8 ]
McCorvy, John D. [9 ]
Kamber, David N. [2 ]
Phelan, James P. [2 ]
Martins, Luan Carvalho [1 ,10 ]
Pogorelov, Vladimir M. [6 ]
DiBerto, Jeffrey F. [3 ]
Slocum, Samuel T. [3 ]
Huang, Xi-Ping [11 ]
Kumar, Jain Manish [3 ]
Robertson, Michael J. [5 ]
Panova, Ouliana [5 ]
Seven, Alpay B. [5 ]
Wetsel, Autumn Q. [6 ]
Wetsel, William C. [6 ,7 ,12 ,13 ]
Irwin, John J. [1 ]
Skiniotis, Georgios [5 ]
Shoichet, Brian K. [1 ]
Roth, Bryan L. [3 ,14 ]
Ellman, Jonathan A. [2 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[3] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA
[4] Yonsei Univ, Dept Pharm, Incheon, South Korea
[5] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA
[6] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA
[7] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27706 USA
[8] Washington Univ, Sch Med, Ctr Clin Pharmacol, Dept Anesthesiol, St Louis, MO USA
[9] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA
[10] Univ Fed Minas Gerais, Inst Biol Sci, Biochem Dept, Belo Horizonte, MG, Brazil
[11] Univ N Carolina, Sch Med, Natl Inst Mental Hearth Psychoact Drug Screening, Chapel Hill, NC 27515 USA
[12] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA
[13] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA
[14] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA
关键词
FREE-ENERGY; PSILOCYBIN TREATMENT; DRUG DISCOVERY; SEROTONIN; LIGANDS; SELECTIVITY; ANXIETY; ACTIVATION; PREDICTION; FEATURES;
D O I
10.1038/s41586-022-05258-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally(1-4). Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines-a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C-H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization(5-7). Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
引用
收藏
页码:582 / +
页数:36
相关论文
共 50 条
  • [41] Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes
    Heslop, KE
    Curzon, G
    NEUROPHARMACOLOGY, 1999, 38 (06) : 883 - 891
  • [42] Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat
    Maurel, S
    Schreiber, R
    De Vry, J
    BEHAVIOURAL PHARMACOLOGY, 1998, 9 (04): : 337 - 343
  • [43] Evidence that constitutive activity of the serotonin 5-HT2A receptor regulates learning
    Harvey, J. A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 5 - 5
  • [44] A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor
    Parker, MA
    Marona-Lewicka, D
    Lucaites, VL
    Nelson, DL
    Nichols, DE
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (26) : 5148 - 5149
  • [45] Further evidence for a role of the 5-HT2A receptor in the mediation of antipsychotic activity
    Wadenberg, MLG
    Hicks, PB
    Young, KA
    Richter, JT
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 83 - 83
  • [46] Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists
    Pottie, Eline
    Poulie, Christian B. M.
    Simon, Icaro A.
    Harpsoe, Kasper
    D'Andrea, Laura
    Komarov, Igor V.
    Gloriam, David E.
    Jensen, Anders A.
    Kristensen, Jesper L.
    Stove, Christophe P.
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (15): : 2727 - 2742
  • [47] Discriminative stimulus effects of DOM in rhesus monkeys: interactions between 5-HT1A and 5-HT2A receptor agonists
    Li, Jun-Xu
    Rice, Kenner C.
    Koek, Wouter
    France, Charles P.
    FASEB JOURNAL, 2009, 23
  • [48] 5-HT1A and 5-HT2A receptor agonists and antagonists modulate behavior and regional DAT binding in the rat brain
    Nikolaus, S.
    Beu, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S460 - S460
  • [49] 5-HT1A receptor sensitivity after 5-HT2A receptor downregulation
    Hensler, JG
    Truett, KA
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 116 - 116
  • [50] Synthesis and 5-HT2A radioligand receptor binding assays of DOMCI and DOMOM, two novel 5-HT2A receptor ligands
    Harms, A
    Ulmer, E
    Kovar, KA
    ARCHIV DER PHARMAZIE, 2003, 336 (03) : 155 - 158